Please turn JavaScript on
Heart Doc VIP with Dr. Joel Kahn icon

Heart Doc VIP with Dr. Joel Kahn

Want to keep yourself up to date with the latest news from Heart Doc VIP with Dr. Joel Kahn?

Subscribe using the "Follow" button below and we provide you with customized updates, via topic or tag, that get delivered to your email address, your smartphone or on your dedicated news page on follow.it.

You can unsubscribe at any time painlessly.

Title of Heart Doc VIP with Dr. Joel Kahn: "Heart Doc VIP with Dr. Joel Kahn"

Is this your feed? Claim it!

Publisher:  Unclaimed!
Message frequency:  0.15 / day

Message History

This week, Dr. Kahn discusses new research showing that after just 4 weeks of eating a whole-food, plant-based diet, sophisticated measures of gene activity demonstrate a reversal in aging and a reduction in inflammation. In another study, the calorie advantage of a plant-based diet is discussed, with the equation H=N/C (Health = Nutrition/Calories) proving to be a useful rem...


Read full story

This week, Dr. Kahn discussed new research on advanced glycation end-products (AGEs) and cooking methods. High levels of AGEs promote many disease states and can be avoided with water-based cooking methods like steaming, boiling, and pressure cooking.

Other topics include visceral fat loss and brain health, bitter hops extract for weight loss, the Planetary Health Diet...


Read full story

This week, Dr. Kahn discusses new data from the amazing Valter Longo, PhD, and his colleagues regarding optimizing diet for both longevity and strong muscles. In a new publication, Dr. Longo used mouse models to show that animals fed a Longevity Diet, as described in his book, lived longer. However, when moderate amounts of methionine, an amino acid, were included in the diet...


Read full story

In this bonus episode, Dr. Kahn interviews functional medicine specialist Ivan Rusilko about the importance of advanced lab panels. Together, they explore the full spectrum of cardiac lab testing, with a special focus on inflammation, insulin resistance, and how these markers can uncover hidden cardiovascular risk.

If you are a health care practitioner, set up an accou...


Read full story

This week, Dr. Kahn discusses the FDA approval of the first oral PCSK9 inhibitor, Lipfendra (enclicitide), taken as a 20 mg daily tablet. In a study of nearly 3,000 patients with elevated LDL cholesterol despite treatment with statins and, in many cases, ezetimibe, LDL-C dropped by more than 50% while Lipoprotein(a) levels fell by 28%, with an excellent safety profile. The me...


Read full story